Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
513 hedge funds and large institutions have $11.5B invested in Exact Sciences in 2020 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 177 increasing their positions, 148 reducing their positions, and 69 closing their positions.
59% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 69
50% more funds holding in top 10
Funds holding in top 10: 8 → 12 (+4)
50% more capital invested
Capital invested by funds: $7.68B → $11.5B (+$3.83B)
20% more repeat investments, than reductions
Existing positions increased: 177 | Existing positions reduced: 148
8% more funds holding
Funds holding: 476 → 513 (+37)
0.99% less ownership
Funds ownership: 89.47% → 88.48% (-0.99%)
15% less call options, than puts
Call options by funds: $186M | Put options by funds: $220M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$142M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$85.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$76.5M |
| 4 |
EC
Eminence Capital
New York
|
+$64.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$60.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$90M |
| 2 |
Jennison Associates
New York
|
-$83.3M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$76M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$61.6M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$54.5M |
EXAS Hedge Fund Activity: Q2 2020 in Review
513 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2020, worth a combined $11.5B — up 50% from $7.68B a quarter earlier.
Buyers outnumbered sellers: 110 funds opened new EXAS positions and 69 closed out — a net gain of 41 holders — while 177 added to existing stakes and 148 trimmed.
The largest buyer was William Blair Investment Management, opening a new position worth an estimated $142M. The largest seller was JP Morgan Chase, cutting an estimated $90M.
- 513 institutional investors held Exact Sciences (EXAS) as of Q2 2020, up from 476 in Q1 2020.
- Funds reported $11.5B of Exact Sciences stock for Q2 2020, up 50% quarter-over-quarter.
- 110 funds opened new Exact Sciences positions in Q2 2020 and 69 closed out, a net change of +41 holders.
- The largest Exact Sciences buyer in Q2 2020 was William Blair Investment Management, an estimated $142M added.
- The largest Exact Sciences seller in Q2 2020 was JP Morgan Chase, an estimated $90M sold.
Based on aggregated 13F filings for Q2 2020.